Medicenna Therapeutics holds annual shareholder meeting

PUBT · 22h ago
Medicenna Therapeutics holds annual shareholder meeting
  • Medicenna held its annual general and special meeting on Oct. 1, 2026.
  • Shareholders selected the board slate put forward in the Aug. 19, 2026 circular.
  • MNP LLP was reappointed as auditor.
  • A share consolidation was authorized, with the ratio to be set by the board within a 1-for-2 to 1-for-20 range.
  • The consolidation was not implemented at the meeting; the board retains discretion to proceed or not.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicenna Therapeutics Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610011900PRIMZONEFULLFEED9838349) on October 01, 2026, and is solely responsible for the information contained therein.